Immunogenicity of SARS inactivated vaccine in BALB/c mice

Immunology Letters
Sheng XiongJiang-lin Fan

Abstract

Severe acute respiratory syndrome (SARS) is a serious infectious threat to public health. To create a novel trial vaccine and evaluate its potency, we attempted to generate a SARS inactivated vaccine using SARS coronavirus (SARS-CoV) strain F69 treated with formaldehyde and mixed with Al(OH)3. Three doses of the vaccine were used to challenge three groups of BALB/c mice. We found that the mice exhibited specific IgM on day 4 and IgG on day 8. The peak titers of IgG were at day 47 in low-dose group (1:19,200) and high-dose group (1:38,400) whereas in middle-dose group (1:19,200), the peak was at day 40. On day 63, the IgG levels reached a plateau. Neutralization assay demonstrated that the antisera could protect Vero-E6 cells from SARS-CoV's infection. Analysis of the antibody specificity revealed that the mouse antisera contained a mixture of antibodies specifically against the structure proteins of SARS-CoV. Furthermore, the mouse antisera conferred higher amount of antibodies against protein N, polypeptide S4 and S2 than those of proteins M and 3CL. These findings suggest that the inactivated SARS-CoV could preserve its antigenicity and the inactivated vaccine can stimulate mice to produce high levels of antibodies with neutr...Continue Reading

Citations

Jan 22, 2005·Respiratory Research·David A GronebergPeter Zabel
Jul 19, 2005·Emerging Infectious Diseases·Shibo JiangShuwen Liu
Sep 18, 2012·Critical Reviews in Microbiology·Derrick LouzRob C Hoeben
Jun 23, 2009·Expert Review of Vaccines·Rachel L Roper, Kristina E Rehm
Aug 14, 2020·Human Vaccines & Immunotherapeutics·Mohamad Hesam ShahrajabianQi Cheng
Jul 23, 2005·Viral Immunology·Yuxian He, Shibo Jiang
Sep 26, 2020·Frontiers in Pharmacology·Rudra P SahaChiranjib Chakraborty
Dec 13, 2005·Microbiology and Molecular Biology Reviews : MMBR·Susan R Weiss, Sonia Navas-Martin
Feb 17, 2009·Expert Opinion on Biological Therapy·Ponraj PrabakaranDimiter S Dimitrov
Dec 1, 2020·Drug Development Research·Fatemeh BabaeiHossein Hosseinzadeh
Feb 13, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ramandeep SinghZhou Xing
Jun 15, 2020·Life Sciences·Satish Chandra PandeyMukesh Samant
Sep 10, 2020·Asian Journal of Pharmaceutical Sciences·Lanxiang HuangFubing Wang
Jun 16, 2021·Journal of Infection and Public Health·Ahmed S KeshtaPatrick Tang
Jun 9, 2005·Protein Expression and Purification·Xun ZuoTauseef R Butt

❮ Previous
Next ❯

Methods Mentioned

BETA
gel filtration
enzyme-linked immunosorbent assay
Chip
ELISA

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.